9/24/24 19:41 | 9/20/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | M.dm | 764 | 51.80 | 0 | 15 | 41 | 51 | D | | | | | | | | | | | | | | |
9/24/24 19:41 | 9/20/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | S.dm | -1,642 | 102.35 | 0 | -16 | -24 | 51 | D | | | | | | | | | | | | | | |
9/18/24 19:55 | 9/16/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | M.d | 338 | 58.49 | 0 | 6 | 12 | 52 | D | | | | | | | | | | | | | | |
8/26/24 20:15 | 8/22/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | S.m | -1,986 | 105.34 | 0 | -19 | -28 | 50 | D | | | | | | | | | | | | | | |
8/13/24 17:21 | 8/9/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | S | -1,797 | 98.50 | 0 | -18 | -21 | 68 | D | | | | | | | | | | | | | | |
5/15/24 19:34 | 5/13/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | S.m | -1,496 | 84.99 | 0 | -18 | -17 | 86 | D | | | | | | | | | | | | | | |
9/3/19 19:34 | 9/3/19 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | CA | O | EVP,Fina | P | 43 | 86.18 | 0 | 1 | 3 | 17 | D | | | | | | | | | | | | | | |
8/29/18 20:35 | 8/29/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | CA | O | EVP,Fina | M.d | 990 | 85.79 | 0 | 12 | | 7 | D | | | | | | | | | | | | | | |
8/29/18 20:35 | 8/29/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | CA | O | EVP,Fina | S.d | -4,712 | 256.69 | 0 | -18 | -73 | 7 | D | | | | | | | | | | | | | | |
11/17/17 17:11 | 11/17/17 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | CA | O | VP,Finan | S | -936 | 142.63 | 0 | -7 | -45 | 8 | D | | | | | | | | | | | | | | |